Life science CIOs must proceed with care to realize the benefits of real-world data in the face of new data privacy regulations and a maturing data vendor ecosystem. Use these Gartner insights to overcome these challenges and gain value from real-world data investments.
- How Can I Best Obtain RWD Data From the Many Data Owners?
- How Will the EU General Data Protection Regulation and Other Regulations Affect My Technology Strategy With Regards to RWD?
- Compliance With RWD Policy
- Patient Authorization
- Do I Need to Hire a Data Scientist to Make Sense of RWD?
- What Are the Applications and Vendor Solutions That Can Best Optimize the Use of RWD Analytics?
- Should I Prioritize Real World Evidence Solutions in 2018? If Not, Then When Should This Be a Priority?
Gartner Recommended Reading
©2020 Gartner, Inc. and/or its affiliates.
All rights reserved.
Gartner is a registered trademark of Gartner, Inc. and its affiliates.
This publication may not be reproduced or distributed in any form without Gartner’s prior written permission.
It consists of the opinions of Gartner’s research organization, which should not be construed as statements of fact.
While the information contained in this publication has been obtained from sources believed to be reliable, Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information.
Although Gartner research may address legal and financial issues, Gartner does not provide legal or investment advice and its research should not be construed or used as such.
Your access and use of this publication are governed by Gartner’s Usage Policy.
Gartner prides itself on its reputation for independence and objectivity.
Its research is produced independently by its research organization without input or influence from any third party.
For further information, see
Guiding Principles on Independence and Objectivity.